Q1 Earnings Estimate for Amedisys Issued By William Blair

Key Points

• William Blair estimates Amedisys will report earnings per share of $0.91 for Q1 2026, with a full-year estimate of $4.40 per share.
• Amedisys' most recent earnings report showed an EPS of $1.54, exceeding expectations by $0.15, with a year-over-year revenue increase of 5.2%.
• Institutional investors continue to increase their stakes in Amedisys, with over 94% of the stock currently held by such entities.

Amedisys, Inc. (NASDAQ:AMED - Free Report) - Equities researchers at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of Amedisys in a research report issued on Tuesday, July 29th. William Blair analyst M. Larew expects that the health services provider will post earnings of $0.91 per share for the quarter. The consensus estimate for Amedisys' current full-year earnings is $4.40 per share.

A number of other equities research analysts have also recently commented on AMED. Wall Street Zen cut Amedisys from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 24th. Royal Bank Of Canada reissued an "outperform" rating and issued a $100.00 target price on shares of Amedisys in a research note on Wednesday, April 16th.

Amedisys Stock Up 1.0%

Shares of AMED stock traded up $0.99 during mid-day trading on Friday, reaching $99.49. 1,251,450 shares of the company's stock traded hands, compared to its average volume of 374,274. Amedisys has a 12 month low of $82.15 and a 12 month high of $99.85. The company has a market cap of $3.27 billion, a P/E ratio of 38.71, a P/E/G ratio of 1.33 and a beta of 0.89. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.26. The company's 50-day moving average price is $96.86 and its 200-day moving average price is $94.24.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The health services provider reported $1.54 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.15. Amedisys had a return on equity of 12.91% and a net margin of 3.56%. The company had revenue of $621.86 million during the quarter, compared to analyst estimates of $614.61 million. During the same quarter last year, the firm posted $0.98 earnings per share. The firm's revenue was up 5.2% on a year-over-year basis.

Institutional Investors Weigh In On Amedisys

Institutional investors have recently modified their holdings of the business. Hexagon Capital Partners LLC lifted its holdings in Amedisys by 108.1% in the first quarter. Hexagon Capital Partners LLC now owns 310 shares of the health services provider's stock valued at $29,000 after acquiring an additional 161 shares during the period. Caitong International Asset Management Co. Ltd bought a new position in shares of Amedisys in the second quarter worth about $32,000. MassMutual Private Wealth & Trust FSB raised its stake in Amedisys by 56.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 334 shares of the health services provider's stock valued at $31,000 after purchasing an additional 120 shares during the period. Fifth Third Bancorp raised its stake in Amedisys by 68.1% during the 1st quarter. Fifth Third Bancorp now owns 348 shares of the health services provider's stock valued at $32,000 after purchasing an additional 141 shares during the period. Finally, UMB Bank n.a. increased its stake in Amedisys by 100.0% in the 1st quarter. UMB Bank n.a. now owns 386 shares of the health services provider's stock worth $36,000 after acquiring an additional 193 shares during the last quarter. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.